BFC Planning’s FibroBiologics FBLG Stock Holding History
Bought
Maintained
Sold
Other funds holding FBLG
BFC Planning's FBLG Position: Q3 2026 in Review
BFC Planning held its FibroBiologics (FBLG) position steady in Q3 2026 at 50 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #3405.
BFC Planning first reported a position in FBLG in Q3 2025 and has held it in 5 quarters since. The position peaked at $546 in Q3 2025. 14 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.
- BFC Planning held 50 shares of FibroBiologics worth $65 as of Q3 2026.
- BFC Planning left its FibroBiologics share count unchanged in Q3 2026.
- FibroBiologics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3405 holding.
- BFC Planning first reported a position in FibroBiologics in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's FibroBiologics position peaked at $546 in Q3 2025.
- 14 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.